Is CBD more than a trendy remedy? Recent studies suggest a positive effect in rheumatoid arthritis.
What is CBD?
CBD is currently almost unavoidable. Everywhere a wide variety of CBD products such as CBD OilCBD tinctures, creams and even bath balls are being advertised everywhere. CBD is sold in its various forms online, in drugstores and pharmacies. And it is supposed to help against almost everything. From nervousness and tension to Sleep disorders to pain, many ailments are said to improve with the help of CBD. With such a large presence in the media and advertising, and such a broad spectrum of effects, the suspicion is obvious that CBD is one thing above all: a trendy drug.
Looking at it objectively, CBD is first of all one of hundreds of cannabinoids found in the hemp plant. However, unlike THC - which is also a cannabinoid - CBD has no psychoactive effects. That is, it is not intoxicating. Therefore, the sale of CBD products is also legal in this country, as long as a maximum level of THC content in the product is not exceeded and thus an intoxicating effect can be excluded. This maximum level is 0.2 percent.
Scientifically, there are now actually some positive effects of CBD. For example, CBD products have been shown to reduce epileptic seizures in children. In most cases, traditional therapies achieve remission in epilepsy patients, but in about one-third, standard medications don't work and they continue to suffer disease-related seizures. Researchers from Mattel Children's Hospital found that certain CBD products significantly reduced these seizures in children with the disease. As a result, CBD is now used to treat rare types of epilepsy, some of which are resistant to treatment.
How CBD affects the body
The fact that cannabinoids have an effect on the human organism is associated with the fact that they dock onto special receptors of the human nervous and immune systems. These receptors and their ligands - their binding molecules - together form the endocannabinoid system (ECS). This ECS was first uncovered in the 1990s by research groups in Israel and the United States. The molecular structure of CBD had already been deciphered at that time. However, the fact that this fundamental interaction of cannabinoids and ECS has been discovered does not mean that the exact mechanisms of action are understood. How the cannabinoids and the docking sites work together in detail is the central question of research on CBD.
Incidentally, with regard to pain therapy, research assumes that the effect of cannabinoids builds up gradually. Thus, there is first an improvement in sleep, with subsequent muscle relaxation and finally a reduction in pain.